Natalizumab Treatment for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia

Hussein Algahtani, Bader Shirah, Hind Abobaker, Nebras Alghanaim, Fatemah Kamel

Research output: Contribution to journalArticlepeer-review

Original languageUndefined
JournalClinical Neuropharmacology
DOIs
Publication statusPublished - Nov 2018

Cite this